NASACORT Drug Patent Profile
✉ Email this page to a colleague
Which patents cover Nasacort, and what generic alternatives are available?
Nasacort is a drug marketed by Chattem Sanofi and Sanofi Aventis Us and is included in three NDAs.
The generic ingredient in NASACORT is triamcinolone acetonide. There are fifty-one drug master file entries for this compound. Seventy-one suppliers are listed for this compound. Additional details are available on the triamcinolone acetonide profile page.
DrugPatentWatch® Litigation and Generic Entry Outlook for Nasacort
A generic version of NASACORT was approved as triamcinolone acetonide by TARO on October 1st, 1986.
AI Research Assistant
Questions you can ask:
- What is the 5 year forecast for NASACORT?
- What are the global sales for NASACORT?
- What is Average Wholesale Price for NASACORT?
Summary for NASACORT
US Patents: | 0 |
Applicants: | 2 |
NDAs: | 3 |
Raw Ingredient (Bulk) Api Vendors: | 82 |
Clinical Trials: | 8 |
Patent Applications: | 4,327 |
Formulation / Manufacturing: | see details |
DailyMed Link: | NASACORT at DailyMed |
Recent Clinical Trials for NASACORT
Identify potential brand extensions & 505(b)(2) entrants
Sponsor | Phase |
---|---|
Gail Gauvreau | N/A |
Stanford University | Phase 4 |
Sanofi | Phase 4 |
US Patents and Regulatory Information for NASACORT
Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Chattem Sanofi | NASACORT | triamcinolone acetonide | AEROSOL, METERED;NASAL | 019798-001 | Jul 11, 1991 | DISCN | No | No | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | ||||
Chattem Sanofi | NASACORT ALLERGY 24 HOUR | triamcinolone acetonide | SPRAY, METERED;NASAL | 020468-002 | Oct 11, 2013 | OTC | Yes | Yes | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | ||||
Sanofi Aventis Us | NASACORT HFA | triamcinolone acetonide | SPRAY, METERED;NASAL | 020784-001 | Apr 7, 2004 | DISCN | No | No | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | ||||
>Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
Expired US Patents for NASACORT
Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | Patent No. | Patent Expiration |
---|---|---|---|---|---|---|---|
Chattem Sanofi | NASACORT | triamcinolone acetonide | AEROSOL, METERED;NASAL | 019798-001 | Jul 11, 1991 | ⤷ Sign Up | ⤷ Sign Up |
>Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >Patent No. | >Patent Expiration |